C4 Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.

About CCCC

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. 

CEO
Andrew J. Hirsch
CEOAndrew J. Hirsch
Employees
121
Employees121
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2015
Founded2015
Employees
121
Employees121

CCCC Key Statistics

Market cap
392.64M
Market cap392.64M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
529.83K
Average volume529.83K
High today
$8.70
High today$8.70
Low today
$7.68
Low today$7.68
Open price
$7.87
Open price$7.87
Volume
928.30K
Volume928.30K
52 Week high
$38.05
52 Week high$38.05
52 Week low
$4.84
52 Week low$4.84

Analyst ratings

62%

of 13 ratings
Buy
61.5%
Hold
23.1%
Sell
15.4%

CCCC Earnings

-$0.69
-$0.46
-$0.23
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.